NCT07383740 Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis
| NCT ID | NCT07383740 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vastra Gotaland Region |
| Condition | Osteo Arthritis Knee and Hip |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-21 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-04-21 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA). Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. After screening for contraindications, participants will perform the aEB-test twice within 1-2 weeks. The investigators hypothezise that the test will demonstrate acceptable test-retest reliability in patients with hip- and/or knee OA. To establish reliability is essential for future studies using this test in this population and may support its integration into routine clinical assessment.
Eligibility Criteria
Inclusion Criteria: * Currently listed on the waiting list for an osteoarthritis rehabilitation program due to clinically diagnosed hip and/or knee osteoarthritis. Exclusion Criteria: * Another primary cause of symptoms or disability, such as inflammatory joint disease or fracture. * Another condition currently causing more symptoms than osteoarthritis, for example fibromyalgia. * Insufficient understanding of written and spoken Swedish. * Medication that affects heart rate. * Contraindications for a submaximal ergometer bicycle test according to the screening protocol, such as heart disease.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07383740 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying Osteo Arthritis Knee and Hip. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07383740 currently recruiting?
Yes, NCT07383740 is actively recruiting participants. Contact the research team at daniel.karsberg.zotterman@vgregion.se for enrollment information.
Where is the NCT07383740 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT07383740 clinical trial?
NCT07383740 is sponsored by Vastra Gotaland Region. The trial plans to enroll 40 participants.